Enhancing hepatic fatty acid oxidation as a strategy for reversing metabolic disorders programmed by maternal undernutrition during gestation

dc.contributor.authorTorrens, Juana María
dc.contributor.authorOrellana Gavaldà, Josep Maria
dc.contributor.authorPalou, Mariona
dc.contributor.authorSánchez, Juana
dc.contributor.authorHerrero Rodríguez, Laura
dc.contributor.authorPicó, Catalina
dc.contributor.authorSerra i Cucurull, Dolors
dc.contributor.authorPalou Oliver, Andreu
dc.date.accessioned2014-10-24T14:34:36Z
dc.date.available2014-10-24T14:34:36Z
dc.date.issued2014-05
dc.date.updated2014-10-24T14:34:36Z
dc.description.abstractBackground/Aims: Moderate maternal calorie-restriction during gestation programmes offspring for a major propensity to develop metabolic alterations in adulthood. We aimed to assess whether increased hepatic fatty-acid oxidation (FAO), at early ages, by gene transfer of Cpt1am (active mutant of carnitine palmitoyltransferase-1a), may be a strategy for reversing metabolic disturbances associated to maternal calorie-restriction during gestation in rats. Methods: AAV-Gfp (control) and AAV-Cpt1am vectors were administered by tail vein injection in 18-day-old control-pups and the offspring of 20% calorie-restricted rats during gestation (CR). After weaning, animals were fed with normal-fat diet. At the age of 4 months, they were moved to HF-diet and sacrificed at the age of 6 months to collect tissues. Locomotive activity, energy expenditure and blood pressure were measured. Results: Under HF-diet, CR-animals showed higher HOMA-IR, adipocyte diameter and hepatic triglyceride accumulation than controls; these alterations were reverted in Cpt1am-injected animals. In liver, this treatment ameliorated inflammatory state, decreased expression of lipogenesis-related genes and partially restored the decreased expression of leptin-receptor occurring in CR-animals. Treatment also reverted the decreased energy expenditure and the increased blood pressure of CR-animals. Conclusion: Increasing hepatic FAO through AAV-Cpt1am injection at juvenile ages prevents some metabolic disorders associated to gestational maternal calorie-restriction.
dc.format.extent18 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec637431
dc.identifier.issn1015-8987
dc.identifier.urihttps://hdl.handle.net/2445/59013
dc.language.isoeng
dc.publisherKarger
dc.relation.isformatofReproducció del document publicat a: http://dx.doi.org/10.1159/000358714
dc.relation.ispartofCellular Physiology and Biochemistry, 2014, vol. 33, num. 5, p. 1498-1515
dc.relation.urihttp://dx.doi.org/10.1159/000358714
dc.rights(c) Karger, 2014
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Bioquímica i Biomedicina Molecular)
dc.subject.classificationÀcids grassos
dc.subject.classificationDieta hipocalòrica
dc.subject.classificationFetge
dc.subject.classificationTeràpia genètica
dc.subject.classificationMalnutrició
dc.subject.classificationComplicacions en l'embaràs
dc.subject.classificationTrastorns del metabolisme
dc.subject.otherFatty acids
dc.subject.otherLow-calorie diet
dc.subject.otherLiver
dc.subject.otherGene therapy
dc.subject.otherMalnutrition
dc.subject.otherDisorders of metabolism
dc.subject.otherComplications of pregnancy
dc.titleEnhancing hepatic fatty acid oxidation as a strategy for reversing metabolic disorders programmed by maternal undernutrition during gestation
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
637431.pdf
Mida:
1.69 MB
Format:
Adobe Portable Document Format